...
首页> 外文期刊>Biochemical and Biophysical Research Communications >Octanoic acid potentiates glucose-stimulated insulin secretion and expression of glucokinase through the olfactory receptor in pancreatic beta-cells
【24h】

Octanoic acid potentiates glucose-stimulated insulin secretion and expression of glucokinase through the olfactory receptor in pancreatic beta-cells

机译:八烷酸增强了葡萄糖刺激的胰岛素分泌,并通过胰腺β细胞中的嗅觉受体表达葡萄糖酮酶

获取原文
获取原文并翻译 | 示例
           

摘要

Olfactory receptors (ORs) are G protein-coupled receptors that mediate olfactory chemosensation, leading to the perception of smell. ORs are expressed in many tissues, but their functions are largely unknown. Here, we show that the olfactory receptor Olfr15 is highly and selectively expressed in both mouse pancreatic beta-cells and MIN6 cells. In addition, octanoic acid (OA), a medium-chain fatty acid, potentiates glucose-stimulated insulin secretion (GSIS). The OA-induced enhancement of GSIS was inhibited by Olfr15 knockdown. Treatment with a PLC inhibitor or an Ins(1,4,5)P-3 receptor (IP3R) antagonist also blocked the OA-induced enhancement of GSIS. These results suggest that OA potentiates GSIS via Olfr15 though the PLC-IP3 pathway. Furthermore, long-term treatment with OA increased cellular glucose uptake in MIN6 cells by up-regulating the expression of glucokinase (GK). Moreover, this process was blocked by an IP3R antagonist and a Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) inhibitor. Similarly, OA stimulated GK promoter activity, while either Olfr15 or CaMKIV knockdown blocked the stimulatory effect of OA on GK promoter activity. These results suggest that long-term treatment of OA induces GK promoter activity via Olfr15 through the IP3-CaMKK/CaMKIV pathway. In islets from type 2 diabetic mice, the expression level of Olfr15 and the OA-induced enhancement of GSIS were strongly reduced. Collectively, our results highlight the crucial role of the olfactory receptor Olfr15 in potentiating GSIS in pancreatic beta-cells, suggesting that Olfr15 may be an important therapeutic target in type 2 diabetes. (C) 2018 Elsevier Inc. All rights reserved.
机译:嗅觉受体(ORS)是G蛋白偶联的受体,其介导嗅觉化学化,导致气味的感知。或者在许多组织中表达,但它们的功能在很大程度上是未知的。这里,我们表明嗅觉受体OLFR15在小鼠胰腺β细胞和MIN6细胞中高度且选择性地表达。此外,辛酸(OA),中链脂肪酸,增强葡萄糖刺激的胰岛素分泌(GSI)。 OA诱导的GSI增强通过OLFR15敲低来抑制。用PLC抑制剂或INS(1,4,5)P-3受体(IP3R)拮抗剂的处理也阻断了GSI的OA诱导的增强。这些结果表明,OA通过OLFR15虽然PLC-IP3途径,但是OA通过OLFR15强调GSIS。此外,通过UP调节葡萄糖酮酶(GK)的表达,在MIN6细胞中使用OA增加细胞葡萄糖摄取的长期处理。此外,该方法由IP3R拮抗剂和Ca2 + /钙调蛋白依赖性蛋白激酶激酶激酶激酶激酶(Camkk)抑制剂阻断。类似地,OA刺激的GK启动子活性,而OLFR15或CAMKIV敲低阻断OA对GK启动子活性的刺激作用。这些结果表明OA的长期治疗通过IP3-CAMKK / CAMKIV途径通过OLFR15诱导GK启动子活性。在来自2型糖尿病小鼠的胰岛中,强烈降低了OLFR15和OA诱导的GSI的表达水平。集体,我们的结果突出了嗅觉受体OLFR15在胰腺β细胞中增强GSIS的关键作用,表明OLFR15可能是2型糖尿病中的重要治疗靶标。 (c)2018年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号